Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-12 · accession 0001193125-26-014117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-15 | 2026-01-12 | TCRT | Jerman Michael Allen | Dir | A - Grant | $2.89 | +5,406 | 9,589 | +129% | +$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | A | A | 5,406 | $2.89 | 9,589 | D | — | — | (F1) Represents shares of common stock issued in lieu of board fees. |